Home > Name List By 3 > 3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione

CAS No 191732-72-6 , 3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione

  • Name: 3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione
  • Synonyms: CC-5013; CC 5013; IMiD3; CDC-501; Revimid; Revlimid (Celgene); 191732-72-6;3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione;Revlimid; CDC 501;
  • CAS Registry Number:
  • Density: 1.46g/cm3
  • Refractive index: 1.672
  • Molecular Weight: 259.26062
  • InchiKey: GOTYRUGSSMKFNF-UHFFFAOYSA-N
  • InChI: InChI=1S/C13H13N3O3/c14-9-3-1-2-7-8(9)6-16(13(7)19)10-4-5-11(17)15-12
    (10)18/h1-3,10H,4-6,14H2,(H,15,17,18)
  • Molecular Formula: C13H13N3O3
  • Molecular Structure:CAS No:191732-72-6 3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione

Related products

Search by region :

Select to

191732-72-6 LENALIDOMIDE

  • United States LGM Pharma [Manufacturer]
  • Tel: 561-981-9994
  • Fax: 561-892-0580
  • Address: 922 Clint Moore Road
    Boca Raton, FL 33487 null,nullUnited States
Contact Supplier

191732-72-6 Lenalidomide

  • United States Tecoland Corporation null
  • Tel: +1-(732)-603-9577
  • Fax: +1-(732)-906-1522
  • Address: 100 Menlo Park Drive, Suite 316, Edison, New Jersey 08837-2428, null,nullUnited States
Contact Supplier

191732-72-6 Lenalidomide(other anti-cancers)

  • Lenalidomide(other anti-cancers) 191732-72-6 Linezolid 165800-03-3 Lumiracoxib 220991-20-8 Lopinavir 192725-17-0 Masitinib 790299-79-5 Maraviroc 376348-65-1
  • China Wuhan Sunrise Technology development company limited [Manufacturers]
  • Tel: +86-27-83314682
  • Fax: 86 27 83314682
  • Address: Floor 5, Wunan Road No.15, Haixia Investment Zone, Wujiashan Wuhan, China Wuhan,HubeiChina
Contact Supplier

191732-72-6 Lenalidomide

Contact Supplier

191732-72-6 Lenalidomide

  • China Huei-Ho International Co., Ltd. [Importer/Exporter]
  • Tel: +86-(21)-6273-7219, 6273-6279
  • Fax: +86-(21)-6129-4387, 62735948
  • Address: 20B,No.2,Lane 600,Peakway Tower,Tianshan Road, Shanghai, shanghai 200051, null,ShanghaiChina
Contact Supplier

191732-72-6 LENALIDOMIDE

  • China Taizhou Creating Chemical Co.,Ltd [Manufacturer]
  • Tel: +86-576-88827176/ +86-576-88820069
  • Fax: +86-576-88822496
  • Address: B Suite 12F,
    Jiangbin Building,Jiaojiang,Taizhou,
    Zhejiang China null,nullChina
Contact Supplier

191732-72-6 Lenalidomide

  • China Taizhou Crene Chempharm Co., Ltd. null
  • Tel: +86-(576)-88813233
  • Fax: +86-(576)-88670057
  • Address: Weiwu Load Economic Developed Zone, Taizhou, Zhejiang 318000, null,nullChina
Contact Supplier

191732-72-6 LENALIDOMIDE

  • China Apichem Chemical Technology Co., Ltd [Manufacturer]
  • Tel: 86-137-6120-5405/ 86-21-3762-3285
  • Address: Apichem Chemical Technology Co., Ltd
    room 102, No.22,lane 288,
    Qianshao Road,
    Pudong, shanghai 201201 China null,nullChina
Contact Supplier

191732-72-6 LENALIDOMIDE

  • China Changzhou Carbochem Co.,Ltd [Manufacturer]
  • Tel: +86-519-86595536/ +86-139-6295-7477 (24 hours)
  • Fax: +86-519-86595296
  • Address: Room 3222,
    JiaHong Century Mansion
    No. 19 YanLing West Road,
    Changzhou Jiangsu,China null,nullChina
Contact Supplier

191732-72-6 Lenalidomide

Contact Supplier

Select to

3/8
Previous 1 2 3 4 5 6 7 8 Next
References of 3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione
Title: Lenalidomide
CAS Registry Number: 191732-72-6
CAS Name: 3-(4-Amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-2,6-piperidinedione
Synonyms: 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline
Manufacturers' Codes: CC-5013
Trademarks: Revimid (Celgene); Revlimid (Celgene)
Molecular Formula: C13H13N3O3
Molecular Weight: 259.26
Percent Composition: C 60.22%, H 5.05%, N 16.21%, O 18.51%
Literature References: Immunomodulatory drug; analog of thalidomide, q.v. Prepn: G. W. Muller et al., US 5635517 (1997 to Celgene); and in vitro TNF-a inhibition: eidem, Bioorg. Med. Chem. Lett. 9, 1625 (1999). LC-MS determn in plasma: T. M. Tohnya et al., J. Chromatogr. B 811, 135 (2004). Clinical evaluation in multiple myeloma: P. G. Richardson et al., Blood 100, 3063 (2002); in myelodysplastic syndromes: A. List et al., N. Engl. J. Med. 352, 549 (2005). Review of development, pharmacology and therapeutic potential: J. B. Bartlett et al., Nature Rev. 4, 314-322 (2004); C. S. Mitsiades, N. Mitsiades, Curr. Opin. Invest. Drugs 5, 635-647 (2004).
Therap-Cat: Immunomodulator.
Keywords: Immunomodulator.